Surveys on Suspected Adverse Effects Related to Coronavirus Disease 2019 Vaccination and the Impact of Early Publication of Results
Objective: The coronavirus disease 2019 (COVID-19) vaccine was a specially approved pharmaceutical in Japan in February 2021. However, several people were concerned about its safety. Therefore, we conducted a survey on our hospital staff with suspected adverse effects related to COVID-19 vaccines an...
Gespeichert in:
| Veröffentlicht in: | Iyakuhin jōhōgaku 2024/05/30, Vol.26(1), pp.28-35 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 35 |
|---|---|
| container_issue | 1 |
| container_start_page | 28 |
| container_title | Iyakuhin jōhōgaku |
| container_volume | 26 |
| creator | Morikawa, Go Kubota, Ken Okazawa, Katsuko Maruyama, Takemasa Chiaki, Tomoshige |
| description | Objective: The coronavirus disease 2019 (COVID-19) vaccine was a specially approved pharmaceutical in Japan in February 2021. However, several people were concerned about its safety. Therefore, we conducted a survey on our hospital staff with suspected adverse effects related to COVID-19 vaccines and promptly published the results on our website. Methods: The current study included hospital staff who received the COVID-19 vaccine. A questionnaire survey on suspected adverse effects was conducted after each vaccination from the first to the fifth dose. Data on the survey results were promptly posted on the hospital’s website. The number of hits and time spent on the site were also evaluated. Then, we examined. the media (newspapers and television) that reported our findings and the content of their coverage. Results: There were no new findings regarding suspected adverse effects of the COVID-19 vaccines. An article published on our website on June 18, 2021, received more than 9,000 page views with an average time spent of > 3 min. Four media outlets reported on our hospital’s articles from June to July 2021, when public interest in the first and second doses of the vaccine was high. Conclusion: The early release of the survey results has provided a source of information for people who want to obtain safety information regarding the adverse effects of the COVID-19 vaccine. |
| doi_str_mv | 10.11256/jjdi.26.28 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_jstag</sourceid><recordid>TN_cdi_proquest_journals_3144519805</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3144519805</sourcerecordid><originalsourceid>FETCH-LOGICAL-j825-34392858198366434389c19903964a9c81227d8040d483095efb364391b6b363</originalsourceid><addsrcrecordid>eNo9kE9LAzEQxYMoWLQnv0DA89b8Nzl4KLVqoaC0It5Cms3aLNvdNckWevaLm1JxDjNvHj_ewABwg9EEY8LFXV2XfkLEhMgzMMJS0oIR-nmeNWW8wEywSzCOsUa5BKYckxH4WQ9h7w4Rdi1cD7F3NrkSTsu9C9HBeVVlI8KVa8zRTx2cdaFrzd6HIcJHH53JGEFYwQ9jrW9N8jnJtJndOrjY9cYm2FVwbkJzgG_DpvH2xGRz5eLQpHgNLirTRDf-m1dg_TR_n70Uy9fnxWy6LGpJeEEZVURyiZWkQrC8SmWxUogqwYyyEhNyX0rEUMkkRYq7akMzp_BGZEGvwO0ptQ_d9-Bi0nU3hDYf1BQzxnMu4pl6OFF1TObL6T74nQkHbULytnH6-GNNhMbHRuS_b7cmaNfSXyDOdpo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3144519805</pqid></control><display><type>article</type><title>Surveys on Suspected Adverse Effects Related to Coronavirus Disease 2019 Vaccination and the Impact of Early Publication of Results</title><source>J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><creator>Morikawa, Go ; Kubota, Ken ; Okazawa, Katsuko ; Maruyama, Takemasa ; Chiaki, Tomoshige</creator><creatorcontrib>Morikawa, Go ; Kubota, Ken ; Okazawa, Katsuko ; Maruyama, Takemasa ; Chiaki, Tomoshige</creatorcontrib><description>Objective: The coronavirus disease 2019 (COVID-19) vaccine was a specially approved pharmaceutical in Japan in February 2021. However, several people were concerned about its safety. Therefore, we conducted a survey on our hospital staff with suspected adverse effects related to COVID-19 vaccines and promptly published the results on our website. Methods: The current study included hospital staff who received the COVID-19 vaccine. A questionnaire survey on suspected adverse effects was conducted after each vaccination from the first to the fifth dose. Data on the survey results were promptly posted on the hospital’s website. The number of hits and time spent on the site were also evaluated. Then, we examined. the media (newspapers and television) that reported our findings and the content of their coverage. Results: There were no new findings regarding suspected adverse effects of the COVID-19 vaccines. An article published on our website on June 18, 2021, received more than 9,000 page views with an average time spent of > 3 min. Four media outlets reported on our hospital’s articles from June to July 2021, when public interest in the first and second doses of the vaccine was high. Conclusion: The early release of the survey results has provided a source of information for people who want to obtain safety information regarding the adverse effects of the COVID-19 vaccine.</description><identifier>ISSN: 1345-1464</identifier><identifier>EISSN: 1883-423X</identifier><identifier>DOI: 10.11256/jjdi.26.28</identifier><language>jpn</language><publisher>Tokyo: Japanese Society of Drug Informatics</publisher><subject>adverse effect ; Coronaviruses ; COVID-19 ; COVID-19 vaccine ; COVID-19 vaccines ; Hospitals ; Immunization ; media ; Polls & surveys ; Public concern ; questionnaire survey ; Side effects ; Surveys ; Vaccines ; Websites</subject><ispartof>Japanese Journal of Drug Informatics, 2024/05/30, Vol.26(1), pp.28-35</ispartof><rights>2024 Japanese Society of Drug Informatics</rights><rights>Copyright Japan Science and Technology Agency 2024</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,1877,27905,27906</link.rule.ids></links><search><creatorcontrib>Morikawa, Go</creatorcontrib><creatorcontrib>Kubota, Ken</creatorcontrib><creatorcontrib>Okazawa, Katsuko</creatorcontrib><creatorcontrib>Maruyama, Takemasa</creatorcontrib><creatorcontrib>Chiaki, Tomoshige</creatorcontrib><title>Surveys on Suspected Adverse Effects Related to Coronavirus Disease 2019 Vaccination and the Impact of Early Publication of Results</title><title>Iyakuhin jōhōgaku</title><addtitle>JPN.J.DRUG INFOM.</addtitle><description>Objective: The coronavirus disease 2019 (COVID-19) vaccine was a specially approved pharmaceutical in Japan in February 2021. However, several people were concerned about its safety. Therefore, we conducted a survey on our hospital staff with suspected adverse effects related to COVID-19 vaccines and promptly published the results on our website. Methods: The current study included hospital staff who received the COVID-19 vaccine. A questionnaire survey on suspected adverse effects was conducted after each vaccination from the first to the fifth dose. Data on the survey results were promptly posted on the hospital’s website. The number of hits and time spent on the site were also evaluated. Then, we examined. the media (newspapers and television) that reported our findings and the content of their coverage. Results: There were no new findings regarding suspected adverse effects of the COVID-19 vaccines. An article published on our website on June 18, 2021, received more than 9,000 page views with an average time spent of > 3 min. Four media outlets reported on our hospital’s articles from June to July 2021, when public interest in the first and second doses of the vaccine was high. Conclusion: The early release of the survey results has provided a source of information for people who want to obtain safety information regarding the adverse effects of the COVID-19 vaccine.</description><subject>adverse effect</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 vaccine</subject><subject>COVID-19 vaccines</subject><subject>Hospitals</subject><subject>Immunization</subject><subject>media</subject><subject>Polls & surveys</subject><subject>Public concern</subject><subject>questionnaire survey</subject><subject>Side effects</subject><subject>Surveys</subject><subject>Vaccines</subject><subject>Websites</subject><issn>1345-1464</issn><issn>1883-423X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kE9LAzEQxYMoWLQnv0DA89b8Nzl4KLVqoaC0It5Cms3aLNvdNckWevaLm1JxDjNvHj_ewABwg9EEY8LFXV2XfkLEhMgzMMJS0oIR-nmeNWW8wEywSzCOsUa5BKYckxH4WQ9h7w4Rdi1cD7F3NrkSTsu9C9HBeVVlI8KVa8zRTx2cdaFrzd6HIcJHH53JGEFYwQ9jrW9N8jnJtJndOrjY9cYm2FVwbkJzgG_DpvH2xGRz5eLQpHgNLirTRDf-m1dg_TR_n70Uy9fnxWy6LGpJeEEZVURyiZWkQrC8SmWxUogqwYyyEhNyX0rEUMkkRYq7akMzp_BGZEGvwO0ptQ_d9-Bi0nU3hDYf1BQzxnMu4pl6OFF1TObL6T74nQkHbULytnH6-GNNhMbHRuS_b7cmaNfSXyDOdpo</recordid><startdate>20240530</startdate><enddate>20240530</enddate><creator>Morikawa, Go</creator><creator>Kubota, Ken</creator><creator>Okazawa, Katsuko</creator><creator>Maruyama, Takemasa</creator><creator>Chiaki, Tomoshige</creator><general>Japanese Society of Drug Informatics</general><general>Japan Science and Technology Agency</general><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20240530</creationdate><title>Surveys on Suspected Adverse Effects Related to Coronavirus Disease 2019 Vaccination and the Impact of Early Publication of Results</title><author>Morikawa, Go ; Kubota, Ken ; Okazawa, Katsuko ; Maruyama, Takemasa ; Chiaki, Tomoshige</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j825-34392858198366434389c19903964a9c81227d8040d483095efb364391b6b363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>2024</creationdate><topic>adverse effect</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 vaccine</topic><topic>COVID-19 vaccines</topic><topic>Hospitals</topic><topic>Immunization</topic><topic>media</topic><topic>Polls & surveys</topic><topic>Public concern</topic><topic>questionnaire survey</topic><topic>Side effects</topic><topic>Surveys</topic><topic>Vaccines</topic><topic>Websites</topic><toplevel>online_resources</toplevel><creatorcontrib>Morikawa, Go</creatorcontrib><creatorcontrib>Kubota, Ken</creatorcontrib><creatorcontrib>Okazawa, Katsuko</creatorcontrib><creatorcontrib>Maruyama, Takemasa</creatorcontrib><creatorcontrib>Chiaki, Tomoshige</creatorcontrib><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Iyakuhin jōhōgaku</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morikawa, Go</au><au>Kubota, Ken</au><au>Okazawa, Katsuko</au><au>Maruyama, Takemasa</au><au>Chiaki, Tomoshige</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surveys on Suspected Adverse Effects Related to Coronavirus Disease 2019 Vaccination and the Impact of Early Publication of Results</atitle><jtitle>Iyakuhin jōhōgaku</jtitle><addtitle>JPN.J.DRUG INFOM.</addtitle><date>2024-05-30</date><risdate>2024</risdate><volume>26</volume><issue>1</issue><spage>28</spage><epage>35</epage><pages>28-35</pages><issn>1345-1464</issn><eissn>1883-423X</eissn><abstract>Objective: The coronavirus disease 2019 (COVID-19) vaccine was a specially approved pharmaceutical in Japan in February 2021. However, several people were concerned about its safety. Therefore, we conducted a survey on our hospital staff with suspected adverse effects related to COVID-19 vaccines and promptly published the results on our website. Methods: The current study included hospital staff who received the COVID-19 vaccine. A questionnaire survey on suspected adverse effects was conducted after each vaccination from the first to the fifth dose. Data on the survey results were promptly posted on the hospital’s website. The number of hits and time spent on the site were also evaluated. Then, we examined. the media (newspapers and television) that reported our findings and the content of their coverage. Results: There were no new findings regarding suspected adverse effects of the COVID-19 vaccines. An article published on our website on June 18, 2021, received more than 9,000 page views with an average time spent of > 3 min. Four media outlets reported on our hospital’s articles from June to July 2021, when public interest in the first and second doses of the vaccine was high. Conclusion: The early release of the survey results has provided a source of information for people who want to obtain safety information regarding the adverse effects of the COVID-19 vaccine.</abstract><cop>Tokyo</cop><pub>Japanese Society of Drug Informatics</pub><doi>10.11256/jjdi.26.28</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1345-1464 |
| ispartof | Japanese Journal of Drug Informatics, 2024/05/30, Vol.26(1), pp.28-35 |
| issn | 1345-1464 1883-423X |
| language | jpn |
| recordid | cdi_proquest_journals_3144519805 |
| source | J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese |
| subjects | adverse effect Coronaviruses COVID-19 COVID-19 vaccine COVID-19 vaccines Hospitals Immunization media Polls & surveys Public concern questionnaire survey Side effects Surveys Vaccines Websites |
| title | Surveys on Suspected Adverse Effects Related to Coronavirus Disease 2019 Vaccination and the Impact of Early Publication of Results |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T09%3A45%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_jstag&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surveys%20on%20Suspected%20Adverse%20Effects%20Related%20to%20Coronavirus%20Disease%202019%20Vaccination%20and%20the%20Impact%20of%20Early%20Publication%20of%20Results&rft.jtitle=Iyakuhin%20j%C5%8Dh%C5%8Dgaku&rft.au=Morikawa,%20Go&rft.date=2024-05-30&rft.volume=26&rft.issue=1&rft.spage=28&rft.epage=35&rft.pages=28-35&rft.issn=1345-1464&rft.eissn=1883-423X&rft_id=info:doi/10.11256/jjdi.26.28&rft_dat=%3Cproquest_jstag%3E3144519805%3C/proquest_jstag%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3144519805&rft_id=info:pmid/&rfr_iscdi=true |